Blank Bio

Blank Bio builds foundation models to understand RNA, powering applications across the entire R&D pipeline from drug design to clinical trials. Key capabilities include state-of-the-art mRNA property prediction that simulates costly experiments, decoding cfRNA to characterize isoform-level function, and identifying RNA signatures for patient stratification and treatment monitoring. The tool targets biopharma researchers and partners, such as Sanofi and GSK, to design better medicines and discover novel biomarkers. While some models are open-source, direct contact is required for full access.